AI assistant
Sending…
Axogen, Inc. — Director's Dealing 2014
Oct 3, 2014
32414_dirs_2014-10-02_1b268d4a-41b7-4141-95da-383da898cb50.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-09-30
Reporting Person: Gold Mark Stephen (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-30 | Common Stock | M | 290 | $1.07 | Acquired | 303261 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | Stock Option (right to Purchase) | $1.07 | M | 290 | Acquired | 2021-09-29 | Common Stock (290) | Direct |
Footnotes
F1: These shares include 174,471 shares held jointly by Dr. Gold and his wife and 127,013 shares held by MJSK, Ltd., an investment trust held by Dr. Gold's family.
More from Axogen, Inc.
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Interim / Quarterly Report
2026
Apr 28
Earnings Release
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3